Timothy R Rebbeck
Timothy R Rebbeck
Dana Farber Cancer Institute and Harvard University
Verified email at
Cited by
Cited by
Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families
D Ford, DF Easton, M Stratton, S Narod, D Goldgar, P Devilee, DT Bishop, ...
The American Journal of Human Genetics 62 (3), 676-689, 1998
Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations
TR Rebbeck, HT Lynch, SL Neuhausen, SA Narod, L Van't Veer, ...
New England Journal of Medicine 346 (21), 1616-1622, 2002
Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality
SM Domchek, TM Friebel, CF Singer, DG Evans, HT Lynch, C Isaacs, ...
Jama 304 (9), 967-975, 2010
Bilateral Prophylactic Mastectomy Reduces Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group
TR Rebbeck, T Friebel, HT Lynch, SL Neuhausen, L Van’t Veer, ...
Journal of clinical oncology 22 (6), 1055-1062, 2004
Metabolic gene polymorphism frequencies in control populations
S Garte, L Gaspari, AK Alexandrie, C Ambrosone, H Autrup, JL Autrup, ...
Cancer Epidemiology Biomarkers & Prevention 10 (12), 1239-1248, 2001
Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers
TR Rebbeck, ND Kauff, SM Domchek
Journal of the National Cancer Institute 101 (2), 80-87, 2009
Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility.
TR Rebbeck
Cancer epidemiology, biomarkers & prevention: a publication of the American …, 1997
Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program
MS Brose, TR Rebbeck, KA Calzone, JE Stopfer, KL Nathanson, ...
Journal of the National Cancer Institute 94 (18), 1365-1372, 2002
BRCA1 Mutations in Women Attending Clinics That Evaluate the Risk of Breast Cancer
FJ Couch, ML DeShano, MA Blackwood, K Calzone, J Stopfer, ...
New England Journal of Medicine 336 (20), 1409-1415, 1997
Type I and II endometrial cancers: have they different risk factors?
VW Setiawan, HP Yang, MC Pike, SE McCann, H Yu, YB Xiang, A Wolk, ...
Journal of Clinical Oncology 31 (20), 2607-2618, 2013
Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers
TR Rebbeck, AM Levin, A Eisen, C Snyder, P Watson, L Cannon-Albright, ...
Journal of the National Cancer Institute 91 (17), 1475-1479, 1999
Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)
N Mavaddat, D Barrowdale, IL Andrulis, SM Domchek, D Eccles, ...
Cancer Epidemiology, Biomarkers & Prevention 21 (1), 134-147, 2012
Risk-reducing salpingo-oophorectomy for the prevention of BRCA1-and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study
ND Kauff, SM Domchek, TM Friebel, ME Robson, J Lee, JE Garber, ...
Journal of clinical oncology 26 (8), 1331, 2008
Comprehensive genomic characterization of long non-coding RNAs across human cancers
X Yan, Z Hu, Y Feng, X Hu, J Yuan, SD Zhao, Y Zhang, L Yang, W Shan, ...
Cancer cell 28 (4), 529-540, 2015
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer
SE Bojesen, KA Pooley, SE Johnatty, J Beesley, K Michailidou, JP Tyrer, ...
Nature genetics 45 (4), 371-384, 2013
Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4
TR Rebbeck, JM Jaffe, AH Walker, AJ Wein, SB Malkowicz
JNCI: Journal of the National Cancer Institute 90 (16), 1225-1229, 1998
Assessment of cumulative evidence on genetic associations: interim guidelines
JPA Ioannidis, P Boffetta, J Little, TR O’Brien, AG Uitterlinden, P Vineis, ...
International journal of epidemiology 37 (1), 120-132, 2008
Approaching health disparities from a population perspective: the National Institutes of Health Centers for Population Health and Health Disparities
RB Warnecke, A Oh, N Breen, S Gehlert, E Paskett, KL Tucker, N Lurie, ...
American journal of public health 98 (9), 1608-1615, 2008
Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer
TR Rebbeck, N Mitra, F Wan, OM Sinilnikova, S Healey, L McGuffog, ...
Jama 313 (13), 1347-1361, 2015
Akt-dependent metabolic reprogramming regulates tumor cell histone acetylation
JV Lee, A Carrer, S Shah, NW Snyder, S Wei, S Venneti, AJ Worth, ...
Cell metabolism 20 (2), 306-319, 2014
The system can't perform the operation now. Try again later.
Articles 1–20